Injectable GHK-Cu protocol: Dose: 1 to 2 mg per injection
Post-meal glucose spikes, the spikes that drive cravings and stall weight loss, remain entirely invisible to most patients
In a Phase IIb, dose-finding, randomised, placebo-controlled trial (SYNERGY-NASH) involving 190 participants with obesity and biopsy-confirmed MASH and stage F2 or F3 fibrosis, once-weekly subcutaneous tirzepatide (5 mg, 10 mg or 15 mg for 52 weeks) resulted in significantly higher rates of MASH resolution without worsening of fibrosis (44%, 56% and 62%, respectively) than placebo (10%)
Ingredients: Glutathione is known as the master antioxidant as it repairs cellular damage, rids the body of free radicals, boosts energy and mental clarity, and eases inflammation
Cysteine has a role in protecting neurons from oxidative stress